By targeting SHP2, an upstream regulator of multiple signaling regulatory pathways (75), we induced tumor vessel remodeling, clustering highly proliferative tumor cells into vascular islands, and reduced tumor inflammation. Here, PTPN11 is linked to neoplasm.